Skip to content
Open access · CC-BY via OpenAlex

Neuroimmune Dysregulation as a Public Health Axis in Neurodegeneration: Decoding Immune Checkpoints, Aging, and Biomarkers in Preclinical Alzheimer's Disease

Arpita Mukherjee

Biomedical Research and Therapy · 2026

Abstract

Alzheimer’s Disease (AD), the leading cause of dementia globally, is increasingly recognized as a multifactorial disorder in which neurodegeneration intersects with systemic immune aging. While classical models emphasize amyloid-β and tau accumulation, accumulating evidence suggests that neuroimmune dysregulation may play a critical role during the earliest, preclinical stages of disease development. This review synthesizes emerging literature on how immune aging, immune checkpoint signaling, and biomarker discovery converge to shape early AD pathophysiology. Age-associated immune remodeling including T-cell exhaustion, impaired antigen presentation, and altered innate immune responses can disrupt central nervous system immune surveillance. In particular, dysregulated signaling through checkpoint molecules such as Programmed Cell Death Protein 1 and Cytotoxic T-Lymphocyte Associated Protein 4 may influence microglial activation states, peripheral immune infiltration, and neuroinflammatory cascades that precede overt neurodegeneration. Advances in neuroimmunology and biomarker technologies including cerebrospinal fluid immune profiling, peripheral immunophenotyping, and molecular neuroimaging are beginning to reveal measurable neuroimmune signatures associated with early disease states. However, important challenges remain regarding biomarker specificity, translational feasibility, and implementation across diverse healthcare systems. By integrating insights from immunology, neuroscience, and public health research, this review proposes that neuroimmune dysfunction represents a trackable component of early AD pathogenesis. Understanding how immune aging interacts with neurodegenerative pathways may help inform future strategies for early risk stratification and preventative intervention.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.15419/bmrat.v13i6.1078
Canonical
link ↗
Fetched
2026-10-16 MST

Cite this

APA
Mukherjee, A. (2026). Neuroimmune Dysregulation as a Public Health Axis in Neurodegeneration: Decoding Immune Checkpoints, Aging, and Biomarkers in Preclinical Alzheimer's Disease. <em>Biomedical Research and Therapy</em>. https://doi.org/10.15419/bmrat.v13i6.1078
Vancouver
Mukherjee A. Neuroimmune Dysregulation as a Public Health Axis in Neurodegeneration: Decoding Immune Checkpoints, Aging, and Biomarkers in Preclinical Alzheimer's Disease. Biomedical Research and Therapy. 2026. doi:10.15419/bmrat.v13i6.1078.
BibTeX
@article{arpita2026Neuroi, title = {Neuroimmune Dysregulation as a Public Health Axis in Neurodegeneration: Decoding Immune Checkpoints, Aging, and Biomarkers in Preclinical Alzheimer's Disease}, author = {Arpita Mukherjee}, journal = {Biomedical Research and Therapy}, year = {2026}, doi = {10.15419/bmrat.v13i6.1078}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings